DelveInsight
0 FOLLOWERS
We are a business consulting firm with deep industry expertise in life science vertical with core focus on pharma and biotech industries. We consistently help our clients in taking sound decisions facilitating better business performances and achieving incredible growth.
Since its inception, DelveInsight has played a pioneering role in providing state of the art services to its clients and..
DelveInsight
6d ago
FDA Grants Approval to Caris Life Sciences for MI Cancer Seek; Johnson & Johnson MedTech Secures FDA IDE Approval for OTTAVA; Organogenesis Shares Positive Interim Data from Second Phase 3 Study of ReNu; LivaNova’s OSPREY Trial Achieves Key Safety and Efficacy Milestones; Hyperfine Launches Advanced Portable MR Brain Imaging Swoop® System Across Europe; Nihon Kohden Strengthens Neurological Solutions Through Ad-Tech Medical Instrument Corporation Acquisition ..read more
DelveInsight
3M ago
CEPI Grants $41.3 Million to Valneva to Enhance Global Access to First Chikungunya Vaccine The ..read more
DelveInsight
3M ago
Obesity is the second leading cause of preventable death, associated with a range of inflammatory ..read more
DelveInsight
3M ago
With an estimated 1 million patients affected in the US, thyroid eye disease is a ..read more
DelveInsight
4M ago
Ulcerative colitis is a type of inflammatory bowel disease of unknown origin that targets the ..read more
DelveInsight
4M ago
In a strategic move aimed at bolstering its portfolio in inflammatory bowel disease (IBD) treatments ..read more
DelveInsight
4M ago
Vyvgart enjoying strong commercial uptake whereas RYSTIGGO is preferred for MuSK+ Myasthenia gravis. What do ..read more
DelveInsight
4M ago
Immutep Announces Promising Outcomes for First-Line Treatment in PD-L1 Negative Head and Neck Squamous Cell ..read more